{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:15:20Z","timestamp":1758402920242},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,11,25]],"date-time":"2010-11-25T00:00:00Z","timestamp":1290643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1038\/nrneph.2010.142","type":"journal-article","created":{"date-parts":[[2010,11,25]],"date-time":"2010-11-25T14:10:42Z","timestamp":1290694242000},"page":"695-696","source":"Crossref","is-referenced-by-count":5,"title":["Hyperhomocysteinemia: a renal and cardiovascular risk factor?"],"prefix":"10.1038","volume":"6","author":[{"given":"Carmine","family":"Zoccali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kitty J.","family":"Jager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,25]]},"reference":[{"key":"BFnrneph2010142_CR1","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1515\/CCLM.2005.172","volume":"43","author":"KS McCully","year":"2005","unstructured":"McCully, K. S. Hyperhomocysteinemia and arteriosclerosis: historical perspectives. Clin. Chem. Lab. Med. 43, 980\u2013986 (2005).","journal-title":"Clin. Chem. Lab. Med."},{"key":"BFnrneph2010142_CR2","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1161\/CIRCULATIONAHA.109.904672","volume":"121","author":"J Heinz","year":"2010","unstructured":"Heinz, J.  et al. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial. Circulation 121, 1432\u20131438 (2010).","journal-title":"Circulation"},{"key":"BFnrneph2010142_CR3","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1001\/jama.2010.490","volume":"303","author":"AA House","year":"2010","unstructured":"House, A. A.  et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. JAMA 303, 1603\u20131609 (2010).","journal-title":"JAMA"},{"key":"BFnrneph2010142_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1086\/302439","volume":"65","author":"LA Kluijtmans","year":"1999","unstructured":"Kluijtmans, L. A.  et al. The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment. Am. J. Hum. Genet. 65, 59\u201367 (1999).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrneph2010142_CR5","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","volume":"325","author":"DS Wald","year":"2002","unstructured":"Wald, D. S., Law, M. & Morris, J. K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325, 1202 (2002).","journal-title":"BMJ"},{"key":"BFnrneph2010142_CR6","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1136\/bmj.39000.486701.68","volume":"333","author":"DS Wald","year":"2006","unstructured":"Wald, D. S., Wald, N. J., Morris, J. K. & Law, M. Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ 333, 1114\u20131117 (2006).","journal-title":"BMJ"},{"key":"BFnrneph2010142_CR7","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.jacc.2005.10.064","volume":"47","author":"S Zoungas","year":"2006","unstructured":"Zoungas, S.  et al. Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J. Am. Coll. Cardiol. 47, 1108\u20131116 (2006).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrneph2010142_CR8","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1056\/NEJMoa055227","volume":"354","author":"KH B\u00f8naa","year":"2006","unstructured":"B\u00f8naa, K. H.  et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N. Engl. J. Med. 354, 1578\u20131588 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneph2010142_CR9","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1001\/jama.2009.1488","volume":"302","author":"DJ de Jager","year":"2009","unstructured":"de Jager, D. J.  et al. Cardiovascular and non-cardiovascular mortality among patients initiating dialysis. JAMA 302, 1782\u20131789 (2009).","journal-title":"JAMA"}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.142","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneph.2010.142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:33:31Z","timestamp":1684470811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneph.2010.142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,25]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["BFnrneph2010142"],"URL":"https:\/\/doi.org\/10.1038\/nrneph.2010.142","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,25]]}}}